Review Article
Neoatherosclerosis after Drug-Eluting Stent Implantation: Roles and Mechanisms
Table 1
Different characteristics of NA between BMS and DES.
| ā | Neointima of BMS | Neointima of DES |
| Tissue components | Smooth muscle cells and proteoglycans-rich extracellular matrix | Fibrin deposition; proteoglycan deposition; larger necrotic; calcified components; and less smooth muscle cells | Lipid-laden plaque | Small | Large | Inflammatory cell infiltration | Less Inflammatory cell infiltration | Many kinds of inflammatory cells: macrophages, multinucleated giant cells, lymphocytes, and granulocytes | Developing time | Slow (>1 year after stenting) | Rapid (<1 year after stenting) | Type of NA | Less of thin-cap NA | Thin-cap NA | Progression | Slow or disappeared | Growing | Prognosis | Relatively stable | High frequency of late stent failure |
|
|